A resource for reactor physicists and engineers and students of nuclear power engineering, this publication provides a comprehensive summary of the thermophysical properties data needed in nuclear ...
Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy in a ...
Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback